ArticleSignal transduction and targeted therapy2022

Targeting folliculin to selectively inhibit mTORC1: a promising strategy for treating nonalcoholic fatty liver disease.

Yan Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.